Reported 1 day ago
A U.S. appeals court has reinstated a whistleblower lawsuit against Novartis, alleging illegal kickbacks to doctors for promoting its multiple sclerosis drug, Gilenya. The court ruled that the whistleblower, Steven Camburn, could proceed with claims that Novartis hosted deceptive speaker events to boost sales, potentially defrauding government health programs. This decision overturns a previous dismissal and brings the case back to a lower court as Gilenya's sales continue to decline amid rising generic competition.
Source: YAHOO